Ascendis may sell its prized asset, says analyst

Investors are concerned that the company’s borrowings, net of cash, have increased 

Aspen shareholders are in for an anticipated disappointment after Africa's largest pharmaceutical company's earnings grew by a mere 1% in the half year to ...

While it will continue selling its brand-name version at the existing price, Lilly will also sell a half-cost ‘authorised generic’

Discovery CEO Adrian Gore talks to Business Day TV about the group’s interim results and its costly new initiatives

CEO Andy Hall says the company will not go into tenders that do not pay because, as a listed company, it cannot afford to do unprofitable business

The pharmaceuticals group said its investment in local manufacturing facilities has paid off

Auris has developed robotic surgical scopes operated with a handheld device that is steered into patients’ lungs to identify cancerous tumours

Sanofi and Regeneron cut list price by 60% to give  US consumers better access and to lower out-of-pocket costs

The company has now earmarked its bio-science division for an additional sale

The tribunal says a proposed merger with Matlosana Medical Health Services would substantially lessen competition in the province

The share has climbed from recent lows, partly on optimism that the forced sales of stock were slowing

The settlement ends a long-standing dispute over medical devices

SA’s biggest private hospital group presented its final argument to the Competition Tribunal

Business Life Healthcare CEO Shrey Viranna joins Business Day TV to discuss the company’s deal with Radiant Life

News of the sale lifted the health company’s share price which plummeted in 2018 amid concerns about its indebtedness